Status:
COMPLETED
Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
Lead Sponsor:
Seoul National University Hospital
Conditions:
Orthostatic; Hypotension, Neurogenic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.
Detailed Description
In patients with neurogenic orthostatic hypotension, the appropriate treatment was identified by comparing the treatment effects and side effects for each treatment drug. In addition, by confirming th...
Eligibility Criteria
Inclusion
- age \>=18 patients who complained of dizziness
- Orthostatic hypotension after 3-minute standing (systolic blood pressure drop \>=20 or diastolic blood pressure drop \>=10
Exclusion
- Drug-induced hypotension, if necessary, evaluate patient after discontinuing the causative drug for one month
- Heart failure or Chronic renal failure
- Patients who cannot or do not want to write questionaires.
- Poor drug compliance
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT02308124
Start Date
November 1 2014
End Date
September 1 2016
Last Update
October 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea